Epilepsy surgery in children with gliomatosis cerebri

Bruno Maton1, Trevor Resnick, Prasanna Jayakar

  • 1The Brain Institute, Miami Children's Hospital, 3200 S.W. 60th Court, Miami, FL 33155, USA.

Epilepsia
|June 15, 2007
PubMed

Insights

Gliomatosis cerebri (GC) can cause difficult-to-treat epilepsy in children. Epilepsy surgery offers an effective treatment option, leading to seizure freedom and improved quality of life for affected individuals.

Area of Science:

  • Pediatric Neurology
  • Neurosurgery
  • Epileptology

Background:

  • Gliomatosis cerebri (GC) is a rare neoplastic disorder.
  • It can manifest as intractable epilepsy in early childhood.
  • Diagnostic challenges arise due to the diffuse nature of the lesions.

Purpose of the Study:

  • To report on the evaluation and surgical treatment of epilepsy in children with GC.
  • To assess the efficacy of epilepsy surgery in this specific patient population.

Main Methods:

  • Retrospective review of children with pathologically proven GC evaluated for epilepsy surgery (1990-2006).
  • Surgical treatment involved debulking and epilepsy control, tailored to presurgical evaluation.
  • Procedures included functional hemispherectomy and focal cortical resection, guided by ECoG in most cases.

Main Results:

  • Four male children with GC and epilepsy were identified, with seizure onset from 4 months to 11 years.
  • Surgical intervention resulted in seizure freedom in all operated cases (mean follow-up 48 months).
  • One non-operated case remained symptomatic, highlighting the benefit of surgical intervention.

Conclusions:

  • GC is a rare but significant cause of medically resistant epilepsy in children.
  • Epilepsy surgery is a highly effective treatment for improving quality of life in these patients.
  • Early diagnosis and surgical consideration are crucial despite diagnostic uncertainties.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...